#Latest news with #CretostimogeneMonotherapyBusiness Insider28-04-2025BusinessBusiness InsiderCG Oncology to hold a conference callManagement discuses results from the Phase 3 BOND-003 Trial of Cretostimogene Monotherapy in high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) on a conference call to be held on April 28 at 8 am. Webcast Link Stay Ahead of the Market: Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Business Insider28-04-2025BusinessBusiness InsiderCG Oncology to hold a conference callManagement discuses results from the Phase 3 BOND-003 Trial of Cretostimogene Monotherapy in high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) on a conference call to be held on April 28 at 8 am. Webcast Link Stay Ahead of the Market: Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
28-04-2025
